In contrast, compound A-treated stroke animals (168,510 ± 104,173) presented GFAP+ve staining in the CC similar to that of saline- and compound G-treated sham animals, but significantly lower than vehicle-treated stroke animals (p = 0.0001). The gene discussed is GFAP; the disease is stroke disorder.